{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T12:21:38Z","timestamp":1774009298118,"version":"3.50.1"},"reference-count":50,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2014,2,1]],"date-time":"2014-02-01T00:00:00Z","timestamp":1391212800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2014,2]]},"DOI":"10.1016\/j.vaccine.2013.11.100","type":"journal-article","created":{"date-parts":[[2013,12,21]],"date-time":"2013-12-21T15:45:13Z","timestamp":1387640713000},"page":"685-692","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"title":["Characterization of protective immune responses promoted by human antigen targets in a urogenital Chlamydia trachomatis mouse model"],"prefix":"10.1016","volume":"32","author":[{"given":"Anja Weinreich","family":"Olsen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"Andersen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8373-7774","authenticated-orcid":false,"given":"Frank","family":"Follmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2013.11.100_bib0005","series-title":"Global prevalence and incidence of selected curable sexually transmitted infections: overview and estimates","year":"2001"},{"key":"10.1016\/j.vaccine.2013.11.100_bib0010","doi-asserted-by":"crossref","first-page":"1680","DOI":"10.1086\/598983","article-title":"Modeling the impact of potential vaccines on epidemics of sexually transmitted Chlamydia trachomatis infection","volume":"199","author":"Gray","year":"2009","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2013.11.100_bib0015","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/0264-410X(95)80022-6","article-title":"A new computer model for estimating the impact of vaccination protocols and its application to the study of Chlamydia trachomatis genital infections","volume":"13","author":"de la Maza","year":"1995","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2013.11.100_bib0020","doi-asserted-by":"crossref","first-page":"1892","DOI":"10.1016\/j.vaccine.2013.01.024","article-title":"Chlamydia trachomatis control requires a vaccine","volume":"31","author":"Brunham","year":"2013","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2013.11.100_bib0025","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1093\/infdis\/162.6.1385","article-title":"Interferon-gamma in endocervical secretions of women infected with Chlamydia trachomatis","volume":"162","author":"Arno","year":"1990","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2013.11.100_bib0030","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1093\/infdis\/173.4.950","article-title":"The epidemiology of Chlamydia trachomatis within a sexually transmitted diseases core group","volume":"173","author":"Moore","year":"1996","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2013.11.100_bib0035","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1086\/432070","article-title":"Immunoepidemiologic profile of Chlamydia trachomatis infection: importance of heat-shock protein 60 and interferon-gamma","volume":"192","author":"Cohen","year":"2005","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2013.11.100_bib0040","doi-asserted-by":"crossref","first-page":"3456","DOI":"10.1016\/j.vaccine.2011.02.057","article-title":"Immunogenicity of a vaccine formulated with the Chlamydia trachomatis serovar F, native major outer membrane protein in a nonhuman primate model","volume":"29","author":"Cheng","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2013.11.100_bib0045","first-page":"317","article-title":"Resolution of murine chlamydial genital infection by the adoptive transfer of a biovar-specific, Th1 lymphocyte clone","volume":"5","author":"Igietseme","year":"1993","journal-title":"Reg Immunol"},{"key":"10.1016\/j.vaccine.2013.11.100_bib0050","doi-asserted-by":"crossref","first-page":"1784","DOI":"10.1128\/IAI.63.5.1784-1789.1995","article-title":"Local Th1-like responses are induced by intravaginal infection of mice with the mouse pneumonitis biovar of Chlamydia trachomatis","volume":"63","author":"Cain","year":"1995","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2013.11.100_bib0055","doi-asserted-by":"crossref","first-page":"4661","DOI":"10.1128\/IAI.63.12.4661-4668.1995","article-title":"Gene knockout mice establish a primary protective role for major histocompatibility complex class II-restricted responses in Chlamydia trachomatis genital tract infection","volume":"63","author":"Morrison","year":"1995","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2013.11.100_bib0060","doi-asserted-by":"crossref","first-page":"6979","DOI":"10.1128\/IAI.68.12.6979-6987.2000","article-title":"Immunity to murine Chlamydia trachomatis genital tract reinfection involves B cells and CD4(+) T cells but not CD8(+) T cells","volume":"68","author":"Morrison","year":"2000","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2013.11.100_bib0065","doi-asserted-by":"crossref","first-page":"3344","DOI":"10.4049\/jimmunol.158.7.3344","article-title":"Immunity to Chlamydia trachomatis is mediated by T helper 1 cells through IFN-gamma-dependent and -independent pathways","volume":"158","author":"Perry","year":"1997","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2013.11.100_bib0070","doi-asserted-by":"crossref","first-page":"3998","DOI":"10.1073\/pnas.90.9.3998","article-title":"Morphologic and antigenic characterization of interferon gamma-mediated persistent Chlamydia trachomatis infection in vitro","volume":"90","author":"Beatty","year":"1993","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.vaccine.2013.11.100_bib0075","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/S0264-410X(97)00206-5","article-title":"Monoclonal immunoglobulin A antibody to the major outer membrane protein of the Chlamydia trachomatis mouse pneumonitis biovar protects mice against a chlamydial genital challenge","volume":"15","author":"Pal","year":"1997","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2013.11.100_bib0080","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1086\/377134","article-title":"Fc receptor-mediated antibody regulation of T cell immunity against intracellular pathogens","volume":"188","author":"Moore","year":"2003","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2013.11.100_bib0085","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1086\/508203","article-title":"Identification of CT521 as a frequent target of Th1 cells in patients with urogenital Chlamydia trachomatis infection","volume":"194","author":"Osen","year":"2006","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2013.11.100_bib0090","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1086\/522524","article-title":"Identification of human T-cell targets recognized during the Chlamydia trachomatis genital infection","volume":"196","author":"Olsen","year":"2007","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2013.11.100_bib0095","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1086\/528378","article-title":"Antigenic profiling of a Chlamydia trachomatis gene-expression library","volume":"197","author":"Follmann","year":"2008","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2013.11.100_bib0100","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1099\/ijs.0.63446-0","article-title":"Comparative study of overlapping genes in bacteria, with special reference to Rickettsia prowazekii and Rickettsia conorii","volume":"55","author":"Sakharkar","year":"2005","journal-title":"Int J Syst Evol Microbiol"},{"key":"10.1016\/j.vaccine.2013.11.100_bib0105","doi-asserted-by":"crossref","first-page":"7209","DOI":"10.1128\/IAI.68.12.7209-7211.2000","article-title":"Murine models of Chlamydia trachomatis genital tract infection: use of mouse pneumonitis strain versus human strains","volume":"68","author":"Morre","year":"2000","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2013.11.100_bib0110","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1128\/IAI.00881-10","article-title":"Vaccination against Chlamydia genital infection utilizing the murine Chlamydia muridarum model","volume":"79","author":"Farris","year":"2011","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2013.11.100_bib0115","first-page":"927","article-title":"Pathogenesis of endometritis and salpingitis in a guinea pig model of chlamydial genital infection","volume":"140","author":"Rank","year":"1992","journal-title":"Am J Pathol"},{"key":"10.1016\/j.vaccine.2013.11.100_bib0120","doi-asserted-by":"crossref","first-page":"675360","DOI":"10.1155\/2011\/675360","article-title":"Nonhuman primate models used to study pelvic inflammatory disease caused by Chlamydia trachomatis","volume":"2011","author":"Bell","year":"2011","journal-title":"Infect Dis Obstet Gynecol"},{"key":"10.1016\/j.vaccine.2013.11.100_bib0125","doi-asserted-by":"crossref","first-page":"8317","DOI":"10.1128\/IAI.73.12.8317-8321.2005","article-title":"Specific-pathogen-free pigs as an animal model for studying Chlamydia trachomatis genital infection","volume":"73","author":"D Vanrompay","year":"2005","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2013.11.100_bib0130","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1046\/j.1365-2567.1997.00378.x","article-title":"B-cell-deficient mice develop complete immune protection against genital tract infection with Chlamydia trachomatis","volume":"92","author":"Johansson","year":"1997","journal-title":"Immunology"},{"key":"10.1016\/j.vaccine.2013.11.100_bib0135","doi-asserted-by":"crossref","first-page":"2441","DOI":"10.4049\/jimmunol.1103032","article-title":"CD4+ T cells are necessary and sufficient to confer protection against Chlamydia trachomatis infection in the murine upper genital tract","volume":"189","author":"Gondek","year":"2012","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2013.11.100_bib0140","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1093\/infdis\/jiq176","article-title":"Murine Chlamydia trachomatis genital infection is unaltered by depletion of CD4+ T cells and diminished adaptive immunity","volume":"203","author":"Morrison","year":"2011","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2013.11.100_bib0145","doi-asserted-by":"crossref","first-page":"7164","DOI":"10.1128\/IAI.72.12.7164-7171.2004","article-title":"Human antibody responses to a Chlamydia-secreted protease factor","volume":"72","author":"Sharma","year":"2004","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2013.11.100_bib0150","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1128\/IAI.01280-06","article-title":"Intranasal vaccination with a secreted chlamydial protein enhances resolution of genital Chlamydia muridarum infection, protects against oviduct pathology, and is highly dependent upon endogenous gamma interferon production","volume":"75","author":"Murthy","year":"2007","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2013.11.100_bib0155","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1111\/j.1574-695X.2008.00527.x","article-title":"Identification and characterization of novel recombinant vaccine antigens for immunization against genital Chlamydia trachomatis","volume":"55","author":"Coler","year":"2009","journal-title":"FEMS Immunol Med Microbiol"},{"key":"10.1016\/j.vaccine.2013.11.100_bib0160","doi-asserted-by":"crossref","first-page":"e3116","DOI":"10.1371\/journal.pone.0003116","article-title":"Cationic liposomes formulated with synthetic mycobacterial cordfactor (CAF01): a versatile adjuvant for vaccines with different immunological requirements","volume":"3","author":"Agger","year":"2008","journal-title":"PLoS ONE"},{"key":"10.1016\/j.vaccine.2013.11.100_bib0165","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1128\/IAI.31.3.1161-1176.1981","article-title":"Purification and partial characterization of the major outer membrane protein of Chlamydia trachomatis","volume":"31","author":"Caldwell","year":"1981","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2013.11.100_bib0170","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1126\/science.282.5389.754","article-title":"Genome sequence of an obligate intracellular pathogen of humans: Chlamydia trachomatis","volume":"282","author":"Stephens","year":"1998","journal-title":"Science"},{"key":"10.1016\/j.vaccine.2013.11.100_bib0175","first-page":"383","article-title":"Comparison of multiple genital tract infections with Chlamydia trachomatis in different strains of female mice","volume":"38","author":"Lyons","year":"2005","journal-title":"J Microbiol Immunol Infect"},{"key":"10.1016\/j.vaccine.2013.11.100_bib0180","doi-asserted-by":"crossref","first-page":"3527","DOI":"10.4049\/jimmunol.157.8.3527","article-title":"Key epitopes on the ESAT-6 antigen recognized in mice during the recall of protective immunity to Mycobacterium tuberculosis","volume":"157","author":"Brandt","year":"1996","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2013.11.100_bib0185","doi-asserted-by":"crossref","first-page":"e10768","DOI":"10.1371\/journal.pone.0010768","article-title":"Protection against Chlamydia promoted by a subunit vaccine (CTH1) compared with a primary intranasal infection in a mouse genital challenge model","volume":"5","author":"Olsen","year":"2013","journal-title":"PLoS ONE"},{"key":"10.1016\/j.vaccine.2013.11.100_bib0190","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1038\/312548a0","article-title":"Therapy with monoclonal antibodies by elimination of T-cell subsets in vivo","volume":"312","author":"Cobbold","year":"1984","journal-title":"Nature"},{"key":"10.1016\/j.vaccine.2013.11.100_bib0195","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1002\/eji.1830170813","article-title":"CD4 monoclonal antibody pairs for immunosuppression and tolerance induction","volume":"17","author":"Qin","year":"1987","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.vaccine.2013.11.100_bib0200","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1093\/infdis\/168.2.415","article-title":"Workshop on in vitro neutralization of Chlamydia trachomatis: summary of proceedings","volume":"168","author":"Byrne","year":"1993","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2013.11.100_bib0205","first-page":"130","article-title":"Identification of 2 Chlamydia trachomatis antigens recognized by synovial fluid T cells from patients with Chlamydia induced reactive arthritis","volume":"23","author":"Gaston","year":"1996","journal-title":"J Rheumatol"},{"key":"10.1016\/j.vaccine.2013.11.100_bib0210","doi-asserted-by":"crossref","first-page":"4554","DOI":"10.4049\/jimmunol.157.10.4554","article-title":"Chlamydia trachomatis major outer membrane protein (MOMP) epitopes that activate HLA class II-restricted T cells from infected humans","volume":"157","author":"Ortiz","year":"1996","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2013.11.100_bib0215","doi-asserted-by":"crossref","first-page":"2269","DOI":"10.1002\/(SICI)1522-2683(19990801)20:11<2269::AID-ELPS2269>3.0.CO;2-D","article-title":"Identification of immunoreactive proteins of Chlamydia trachomatis by Western blot analysis of a two-dimensional electrophoresis map with patient sera","volume":"20","author":"Sanchez-Campillo","year":"1999","journal-title":"Electrophoresis"},{"key":"10.1016\/j.vaccine.2013.11.100_bib0220","doi-asserted-by":"crossref","first-page":"6905","DOI":"10.4049\/jimmunol.173.11.6905","article-title":"Human CD8+ T cells recognize the 60-kDa cysteine-rich outer membrane protein from Chlamydia trachomatis","volume":"173","author":"Gervassi","year":"2004","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2013.11.100_bib0225","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1110\/ps.03479604","article-title":"Predicting subcellular localization of proteins for Gram-negative bacteria by support vector machines based on n-peptide compositions","volume":"13","author":"Yu","year":"2004","journal-title":"Protein Sci"},{"key":"10.1016\/j.vaccine.2013.11.100_bib0230","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1086\/590670","article-title":"Liposome delivery of Chlamydia muridarum major outer membrane protein primes a Th1 response that protects against genital chlamydial infection in a mouse model","volume":"198","author":"Hansen","year":"2008","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2013.11.100_bib0235","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1111\/j.1365-2958.2011.07802.x","article-title":"Chlamydia trachomatis Slc1 is a type III secretion chaperone that enhances the translocation of its invasion effector substrate TARP","volume":"82","author":"Brinkworth","year":"2011","journal-title":"Mol Microbiol"},{"key":"10.1016\/j.vaccine.2013.11.100_bib0240","doi-asserted-by":"crossref","first-page":"4168","DOI":"10.1128\/IAI.00344-09","article-title":"CT043, a protective antigen that induces a CD4+ Th1 response during Chlamydia trachomatis infection in mice and humans","volume":"77","author":"Meoni","year":"2009","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2013.11.100_bib0245","doi-asserted-by":"crossref","first-page":"6240","DOI":"10.1128\/IAI.69.10.6240-6247.2001","article-title":"Immunization with the Chlamydia trachomatis mouse pneumonitis major outer membrane protein can elicit a protective immune response against a genital challenge","volume":"69","author":"Pal","year":"2001","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2013.11.100_bib0250","doi-asserted-by":"crossref","first-page":"45862","DOI":"10.1074\/jbc.M109494200","article-title":"A single amidotransferase forms asparaginyl-tRNA and glutaminyl-tRNA in Chlamydia trachomatis","volume":"276","author":"Raczniak","year":"2001","journal-title":"J Biol Chem"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X13016952?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X13016952?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,7,9]],"date-time":"2023-07-09T07:44:47Z","timestamp":1688888687000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X13016952"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,2]]},"references-count":50,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2014,2]]}},"alternative-id":["S0264410X13016952"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2013.11.100","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2014,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Characterization of protective immune responses promoted by human antigen targets in a urogenital Chlamydia trachomatis mouse model","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2013.11.100","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}